✦ LIBER ✦

6517 International phase 2 trial of ABT-869 in patients with advanced hepatocellular carcinoma (HCC)

✍ Scribed by Toh, H.C.; Chen, P.; Knox, J.J.; Gill, S.; Carlson, D.M.; Qian, J.; Ricker, J.L.; Yong, W.

Book ID: 122434625
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 67 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71239-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 trial of linifanib (ABT-869) in

Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma

✍ Han Chong Toh; Pei-Jer Chen; Brian I. Carr; Jennifer J. Knox; Sharlene Gill; Pet 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 958 KB

6517 POSTER Sunitinib and Transarterial

6517 POSTER Sunitinib and Transarterial Chemoembolization (TACE) for Advanced Hepatocellular Carcinoma (HCC)- Final Results of a Phase 2 Trial

✍ Iyer, R.; Fetterly, G.; Groman, A.; Hutson, A.; Khushalani, N.; Mohile, S.; Asht 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Phase 2 trial of linifanib (ABT-869) in

Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failure

✍ Nizar M. Tannir; Yu-Ning Wong; Christian K. Kollmannsberger; Marc S. Ernstoff; D 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 322 KB

A phase II trial of gemcitabine in patie

A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma

✍ Charles S. Fuchs; Jeffrey W. Clark; David P. Ryan; Mathew H. Kulke; Haesook Kim; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

## Abstract ## BACKGROUND There is no effective systemic therapy for patients with hepatocellular carcinoma. A recent trial reported a moderate antitumor activity for gemcitabine among Asian patients with advanced hepatocellular carcinoma. This led to our examination of the efficacy and tolerabili

42 Phase II study of BAY 43-9006 in pati

42 Phase II study of BAY 43-9006 in patients with advanced hepatocellular carcinoma (HCC)

✍ G.K. Abou-Alfa; S. Ricci; D. Amadori; A. Santoro; A. Figer; J. De Greve; J. Doui 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 293 KB

Phase 2 study of cetuximab in patients w

Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma

✍ Andrew X. Zhu; Keith Stuart; Lawrence S. Blaszkowsky; Alona Muzikansky; Donald P 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 1 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor (EGFR) and ligand expression is frequently seen in hepatocellular carcinoma (HCC). A phase 2 study was performed with cetuximab, a chimeric monoclonal antibody that binds specifically to EGFR, in patients with advanced HCC. ## METHODS.